Enanta Pharmaceuticals, Inc. (ENTA)
13.18
-0.34
(-2.55%)
USD |
NASDAQ |
May 27, 16:00
13.00
-0.18
(-1.40%)
After-Hours: 18:43
Enanta Pharmaceuticals Free Cash Flow : -9.609M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Cyclerion Therapeutics, Inc. | -3.588M |
| Keros Therapeutics, Inc. | -58.25M |
| ACADIA Pharmaceuticals, Inc. | 113.59M |
| Alnylam Pharmaceuticals, Inc. | 641.34M |
| Amgen, Inc. | 8.597B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -7.156M |
| Cash from Investing (Quarterly) | 11.94M |
| Cash from Financing (Quarterly) | -7.295M |
| Free Cash Flow Per Share (Quarterly) | -0.2469 |
| Free Cash Flow to Equity (Quarterly) | -0.605M |
| Free Cash Flow to Firm (Quarterly) | -3.853M |
| Free Cash Flow Yield | -2.90% |